Design Therapeutics, Inc.DSGNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-70M

-40.7% YoY

Free Cash Flow

$-55M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	-0	-1↓15.2%	-1↓11.0%	-1↓4.4%
Operating Income	-36	-68↓88.6%	-78↓15.7%	-62↑20.2%	-79↓27.4%
Net Income	-36	-63↓78.2%	-67↓5.6%	-50↑25.8%	-70↓40.7%
EBITDA	-36	-63↓76.0%	-66↓5.5%	-49↑26.1%	-79↓60.9%
EPS Diluted	-0.77	-1.14↓48.1%	-1.19↓4.4%	-0.88↑26.1%	-1.22↓38.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	299	27↓91.1%	21↓20.0%	23↑6.4%	17↓25.3%
Total Current Assets	385	335↓13.1%	285↓15.1%	248↓12.8%	224↓9.8%
Total Assets	391	341↓12.7%	290↓15.1%	252↓13.0%	226↓10.3%
Total Current Liabilities	5	11↑104.0%	10↓10.7%	8↓12.1%	13↑54.3%
Total Liabilities	8	14↑64.1%	12↓13.5%	10↓16.4%	14↑37.1%
Total Equity	382	327↓14.3%	278↓15.2%	242↓12.8%	213↓12.2%
Total Debt	4	4↑1.6%	3↓17.4%	2↓23.5%	1↓72.4%
Net Debt	-295	-23↑92.3%	-18↑20.4%	-20↓11.5%	-16↑19.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-29	-51↓74.7%	-59↓14.1%	-43↑26.4%	-54↓26.1%
Capital Expenditure	-2	-1↑40.3%	-0↑72.1%	-0↓32.8%	-0↑43.2%
Free Cash Flow	-31	-52↓69.0%	-59↓12.6%	-43↑26.1%	-55↓25.6%
Stock-Based Comp	5	11↑133.0%	13↑19.8%	13↓0.1%	15↑11.3%
Net Change in Cash	296	-272↓191.9%	-5↑98.1%	1↑125.7%	-6↓518.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance